Interstitial Lung Disease Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For people with IPF (Idiopathic Pulmonary Fibrosis):

• People who have been diagnosed with IPF within the last 5 years, using recognised international diagnostic standards
• People aged 40 or older
• People who have never had a lung transplant
• People whose lungs are functioning at 45% or more of the expected capacity for their age and size (based on a breathing test called FVC)
• People whose lungs are able to transfer oxygen into the blood at 25% or more of the expected level (based on a breathing test called DLCO)
• Women who could become pregnant must be willing and able to use highly effective contraception, and if taking the oral contraceptive pill, must also use an additional barrier method (such as a condom)

For people with non-IPF ILD (other types of scarring lung disease):

• People who have been diagnosed with a non-IPF lung scarring condition within the last 5 years
• People aged 18 or older
• People whose lung scans show a certain level of scarring or structural changes, as assessed visually by a specialist (confirm with trial site for specific details)
• People who are taking immune-suppressing medications (other than steroids) for an underlying condition must have been on a stable dose for at least 12 weeks before the screening visit
• People whose lungs are functioning at 45% or more of expected capacity (FVC)
• People whose lungs transfer oxygen at 25% or more of the expected level (DLCO)
• Women who could become pregnant must be willing and able to use highly effective contraception, and if taking the oral contraceptive pill, must also use an additional barrier method

Who may not be able to join:

• People who are planning to take part in another clinical intervention trial within the next 6 months
• People who are already on the waiting list for a lung transplant at the time of enrolment
• People who have had most types of cancer in the past 5 years (some exceptions may apply for certain low-risk cancers such as skin cancer or non-spreading prostate cancer — confirm with trial site)
• People with another serious health condition that, in the treating doctor's view, is likely to affect survival or the ability to complete breathing tests within the next 2 years
• People whose breathing test results show a specific airflow pattern that suggests another lung condition (a ratio below 0.7 on a test called FEV1/FVC — confirm with trial site)
• People with certain other conditions, including heart failure, recent stroke, blood clots, heart attack, an active respiratory infection, smoking-related lung disease with significantly reduced airflow, or a history of lung cancer
• People with a history of other cancers treated within the past 4 years (for IPF) or 5 years (for non-IPF ILD), not including a type of minor skin cancer called basal cell carcinoma

Important: Always verify eligibility with the trial site directly before applying.